• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钴-芥子气复合物缺氧选择性毒性的脉冲辐解研究

Pulse radiolysis studies on the hypoxia-selective toxicity of a colbalt-mustard complex.

作者信息

Anderson R F, Denny W A, Ware D C, Wilson W R

机构信息

Department of Chemistry, University of Auckland, New Zealand.

出版信息

Br J Cancer Suppl. 1996 Jul;27:S48-51.

PMID:8763845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2149997/
Abstract

The kinetic basis for the in vitro hypoxia-selective cytotoxicity (HSC) of the Co(III)-nitrogen mustard complex SN 24771 (NSC 675352) has been investigated using pulse radiolysis. The rate constants for the one-electron reduction of SN 24771 by model reductants exhibited a marked dependence on the one-electron reduction potential of the reductant, with values up to several orders of magnitude slower than for the nitroimidazole drug misonidazole. Following one-electron reduction to form the Co(II) complex (species I) consecutive conversion to further transient species (II and III) occurs with first order rate constants of 120 +/- 10 s-1 and 10 +/- 2 s-1 and are associated with release of ligands. Neither of these subsequent processes are inhibited by the addition of O2 up to a concentration of 0.5 mmol l-1 suggesting that the HSC action of SN 24771 most likely arises from a mechanism other than simple redox cycling between the Co(III) and Co(II) forms by O2. If the measured low rate constants of one-electron reduction by model reductants of SN 24771 (as compared to the reduction of nitroaromatics), is mirrored by biological reductants, then it is proposed that HSC may occur through competition between SN 24771 and O2 for these reductants.

摘要

已使用脉冲辐解研究了钴(III)-氮芥配合物SN 24771(NSC 675352)体外缺氧选择性细胞毒性(HSC)的动力学基础。模型还原剂对SN 24771进行单电子还原的速率常数对还原剂的单电子还原电位表现出显著依赖性,其值比硝基咪唑药物米索硝唑慢几个数量级。单电子还原形成钴(II)配合物(物种I)后,会以120±10 s⁻¹和10±2 s⁻¹的一级速率常数连续转化为其他瞬态物种(II和III),且与配体释放有关。在添加浓度高达0.5 mmol l⁻¹的O₂时,这些后续过程均未受到抑制,这表明SN 24771的HSC作用最有可能源于一种不同于O₂使钴(III)和钴(II)形式之间简单氧化还原循环的机制。如果SN 24771的模型还原剂单电子还原的低速率常数(与硝基芳烃的还原相比)能被生物还原剂反映出来,那么有人提出HSC可能是通过SN 24771和O₂对这些还原剂的竞争而发生的。

相似文献

1
Pulse radiolysis studies on the hypoxia-selective toxicity of a colbalt-mustard complex.钴-芥子气复合物缺氧选择性毒性的脉冲辐解研究
Br J Cancer Suppl. 1996 Jul;27:S48-51.
2
Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.双齿氮芥的双(二烷基)二硫代氨基甲酰钴(III)配合物:作为缺氧选择性细胞毒素的合成、还原化学及生物学评价
Anticancer Drug Des. 1998 Mar;13(2):81-103.
3
Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771.
Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):323-7. doi: 10.1016/0360-3016(94)90283-6.
4
Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.缺氧选择性抗肿瘤剂。7. 脂肪族芥子气的金属配合物作为一类新型的缺氧选择性细胞毒素。双齿芥子气钴(III)配合物的合成与评价。
J Med Chem. 1993 Jun 25;36(13):1839-46. doi: 10.1021/jm00065a006.
5
Reduction of nitroarylmethyl quaternary ammonium prodrugs of mechlorethamine by radiation.辐射对氮芥的硝基芳基甲基季铵前药的还原作用。
Radiat Res. 1998 Mar;149(3):237-45.
6
A novel design strategy for stable metal complexes of nitrogen mustards as bioreductive prodrugs.
J Med Chem. 2004 Nov 4;47(23):5683-9. doi: 10.1021/jm049866w.
7
Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction.3-氨基-1,2,4-苯并三嗪-1,4-二氧化物抗肿瘤剂经单电子还原后被激活为氧化物种。
J Am Chem Soc. 2003 Jan 22;125(3):748-56. doi: 10.1021/ja0209363.
8
Nitro analogues of chlorambucil as potential hypoxia-selective anti-tumour drugs.
Anticancer Drug Des. 1990 Nov;5(4):337-49.
9
Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamine.缺氧激活前药的氧依赖性和血管外转运:二硝基苯甲酰胺氮芥PR-104A与替拉扎明的比较
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):560-71. doi: 10.1016/j.ijrobp.2007.05.049.
10
Antagonism in effectiveness of evofosfamide and doxorubicin through intermolecular electron transfer.通过分子间电子转移拮抗依氟鸟氨酸和阿霉素的疗效。
Free Radic Biol Med. 2017 Dec;113:564-570. doi: 10.1016/j.freeradbiomed.2017.10.385. Epub 2017 Oct 28.

引用本文的文献

1
Synthesis and Characterization of Novel Co(III)/Ru(II) Heterobimetallic Complexes as Hypoxia-Activated Iron-Sequestering Anticancer Prodrugs.新型Co(III)/Ru(II)异双金属配合物作为缺氧激活的铁螯合抗癌前药的合成与表征
Molecules. 2024 Dec 18;29(24):5967. doi: 10.3390/molecules29245967.
2
Development of a cobalt(iii)-based ponatinib prodrug system.基于钴(III)的波纳替尼前药系统的开发。
Inorg Chem Front. 2021 Mar 30;8(10):2468-2485. doi: 10.1039/d1qi00211b.
3
Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.提高 EGFR 抑制剂钴(III)前药的稳定性。
Inorg Chem. 2020 Dec 7;59(23):17794-17810. doi: 10.1021/acs.inorgchem.0c03083. Epub 2020 Nov 21.
4
Hypoxia-targeted drug delivery.缺氧靶向药物递送。
Chem Soc Rev. 2019 Feb 4;48(3):771-813. doi: 10.1039/c8cs00304a.
5
Targeting hypoxia in the leukemia microenvironment.靶向白血病微环境中的缺氧状态。
Int J Hematol Oncol. 2013 Aug 1;2(4):279-288. doi: 10.2217/IJH.13.32.
6
Synthesis, characterization, and antibacterial and anticancer screening of {M(2+)-Co (3+)-M (2+)} and {Co (3+)-M (2+)} (M is Zn, Cd, Hg) heterometallic complexes.{M(2+)-Co(3+)-M(2+)} 和 {Co(3+)-M(2+)}(M 为 Zn、Cd、Hg)杂金属配合物的合成、表征及抗菌和抗癌筛选。
J Biol Inorg Chem. 2012 Dec;17(8):1217-30. doi: 10.1007/s00775-012-0937-5. Epub 2012 Sep 23.
7
Redox activation of metal-based prodrugs as a strategy for drug delivery.基于氧化还原的金属前药激活策略用于药物递送。
Adv Drug Deliv Rev. 2012 Aug;64(11):993-1004. doi: 10.1016/j.addr.2012.01.007. Epub 2012 Jan 25.
8
Anticancer activity of metal complexes: involvement of redox processes.金属配合物的抗癌活性:氧化还原过程的参与。
Antioxid Redox Signal. 2011 Aug 15;15(4):1085-127. doi: 10.1089/ars.2010.3663. Epub 2011 May 11.
9
Cellular uptake and distribution of cobalt complexes of fluorescent ligands.荧光配体钴配合物的细胞摄取与分布
J Biol Inorg Chem. 2008 Aug;13(6):861-71. doi: 10.1007/s00775-008-0374-7. Epub 2008 Apr 17.
10
Recent developments in the design of bioreductive drugs.生物还原药物设计的最新进展。
Br J Cancer Suppl. 1996 Jul;27:S32-8.

本文引用的文献

1
Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.缺氧选择性抗肿瘤剂。7. 脂肪族芥子气的金属配合物作为一类新型的缺氧选择性细胞毒素。双齿芥子气钴(III)配合物的合成与评价。
J Med Chem. 1993 Jun 25;36(13):1839-46. doi: 10.1021/jm00065a006.
2
Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs).可生物还原的芥子气:可扩散细胞毒素(HPDC)的低氧选择性前药范例。
Cancer Metastasis Rev. 1993 Jun;12(2):135-51. doi: 10.1007/BF00689806.
3
Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771.
Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):323-7. doi: 10.1016/0360-3016(94)90283-6.
4
Efficient redox cycling of nitroquinoline bioreductive drugs due to aerobic nitroreduction in Chinese hamster cells.中国仓鼠细胞中需氧硝基还原导致硝基喹啉生物还原药物的高效氧化还原循环
Biochem Pharmacol. 1995 Jun 29;50(1):75-82. doi: 10.1016/0006-2952(95)00112-d.
5
Correlation of kinetic parameters of nitroreductase enzymes with redox properties of nitroaromatic compounds.硝基还原酶的动力学参数与硝基芳香族化合物氧化还原性质的相关性。
J Biol Chem. 1989 Jul 25;264(21):12379-84.